Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$2.05B |
| 3 |
Alibaba
BABA
|
+$905M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$371M |
| 5 |
Kroger
KR
|
+$307M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.38B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.33B |
| 3 |
Microsoft
MSFT
|
+$961M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$803M |
| 5 |
Amazon
AMZN
|
+$740M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.8% |
| 2 | Healthcare | 9.1% |
| 3 | Financials | 9.05% |
| 4 | Consumer Discretionary | 8.76% |
| 5 | Communication Services | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
CALL
Intuitive Surgical
ISRG
$133B
| $8.09M | ﹤0.01% |
42,600
-23,400
| -35% | -$4.19M |
|
2402
CRISPR Therapeutics
CRSP
$5.17B
| $8.09M | ﹤0.01% |
110,058
+5,657
| +5% | +$331K |
|
2403
PUT
LendingTree
TREE
$475M
| $8.08M | ﹤0.01% |
27,900
| – | – |
|
2404
PUT
ExxonMobil
XOM
$628B
| $8.06M | ﹤0.01% |
180,200
-208,800
| -54% | -$9.36M |
|
2405
PUT
Ovintiv
OVV
$16B
| $8.06M | ﹤0.01% |
+843,800
| New | +$5.88M |
|
2406
Cenovus Energy
CVE
$51.1B
| $8.04M | ﹤0.01% |
1,721,565
-21,879,187
| -93% | -$84.1M |
|
2407
PUT
Las Vegas Sands
LVS
$29.7B
| $8.02M | ﹤0.01% |
176,000
-184,300
| -51% | -$8.66M |
|
|
TSE
2408
DELISTED
Trinseo
TSE
| $8M | ﹤0.01% |
360,841
-59,203
| -14% | -$1.21M |
|
2409
G-III Apparel Group
GIII
$1.54B
| $7.98M | ﹤0.01% |
600,261
-57,009
| -9% | -$630K |
|
2410
CALL
Fidelity National Financial
FNF
$13.8B
| $7.97M | ﹤0.01% |
+270,400
| New | +$7.44M |
|
2411
Tenable Holdings
TENB
$3.97B
| $7.95M | ﹤0.01% |
266,711
+200,029
| +300% | +$5.43M |
|
2412
iShares Global REIT ETF
REET
$5.13B
| $7.94M | ﹤0.01% |
380,224
+11,043
| +3% | +$223K |
|
2413
YPF
YPF
$19.1B
| $7.94M | ﹤0.01% |
1,380,671
+778,457
| +129% | +$3.63M |
|
|
IMGN
2414
DELISTED
Immunogen Inc
IMGN
| $7.92M | ﹤0.01% |
1,721,556
+724,894
| +73% | +$3.08M |
|
2415
CEL-SCI Corp
CVM
$26.6M
| $7.91M | ﹤0.01% |
17,675
+16,493
| +1,395% | +$6.77M |
|
2416
PUT
AB InBev
BUD
$168B
| $7.89M | ﹤0.01% |
160,100
+2,600
| +2% | +$122K |
|
2417
BrightView Holdings
BV
$988M
| $7.87M | ﹤0.01% |
702,695
+633,037
| +909% | +$7.66M |
|
|
AIOS
2418
AIOS Tech
AIOS
$39.2M
| $7.87M | ﹤0.01% |
2,391
+583
| +32% | +$1.46M |
|
|
ADAM
2419
Adamas Trust
ADAM
$848M
| $7.86M | ﹤0.01% |
753,166
-824,085
| -52% | -$7.23M |
|
|
LTC
2420
LTC Properties
LTC
$1.98B
| $7.85M | ﹤0.01% |
208,513
-1,240
| -0.6% | -$44.2K |
|
2421
Wipro
WIT
$19.8B
| $7.85M | ﹤0.01% |
4,743,786
-3,198,660
| -40% | -$5.01M |
|
2422
Invesco S&P 500 Low Volatility ETF
SPLV
$7.22B
| $7.84M | ﹤0.01% |
157,920
+123,861
| +364% | +$6.09M |
|
2423
Sociedad Química y Minera de Chile
SQM
$20B
| $7.79M | ﹤0.01% |
298,787
+37,548
| +14% | +$903K |
|
2424
PUT
Beyond Meat
BYND
$314M
| $7.74M | ﹤0.01% |
+57,800
| New | +$6.84M |
|
2425
PUT
Newmont
NEM
$110B
| $7.72M | ﹤0.01% |
125,100
-144,900
| -54% | -$8.58M |
|
Similar funds
Goldman Sachs's Q2 2020 Portfolio in Review
As of Q2 2020, Goldman Sachs held 5,697 positions worth $329B, up 16% from $284B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Goldman Sachs withdrew a net $19.5B in Q2 2020, closing 535 positions and reducing 2,401 holdings. Its most notable exit was Allergan plc, an estimated $1.33B position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Goldman Sachs MarketBeta US Equity ETF worth $209M.
- Goldman Sachs's largest Q2 2020 buy was Goldman Sachs MarketBeta US Equity ETF: 4,910,076 shares worth $209M.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $2.58B increase.
- Goldman Sachs's biggest Q2 2020 reduction was Apple, cutting an estimated $1.38B.
- Goldman Sachs fully exited Allergan plc in Q2 2020, selling an estimated $1.33B.
- Goldman Sachs's ten largest holdings make up 19% of its $329B portfolio in Q2 2020.
- Goldman Sachs opened 507 new positions and closed 535 in Q2 2020.
- Goldman Sachs's portfolio value rose 16% quarter-over-quarter to $329B.
Based on Goldman Sachs's 13F filing for Q2 2020, filed 12 Aug 2020.